Owning Obesity & Negating NASH: Awesome Assignments for the 21st century
Hosted by dr. Onno Holleboom and dr. Eveline Bruinstroop
Organized by Onno Holleboom, Victor Gerdes, Eveline Bruinstroop, Anne-Marieke van Dijk, Anne Linde Mak and Eva Dirkx
Due to the COVID-19 situation, we changed the symposium planned on November 5th into a webinar series on November 5th, 12th, 19th and 26th. Please join us for these four episodes.
If you register you will receive a reminder of the episodes and the link to the ZOOM the day before the episodes take place. If you already registered for the symposium planned on November 5th, you will automatically receive the reminder, so you don't have to register again.
EPISODE 3 Clinical insights in NAFLD
THURSDAY
November 19, 2020
15:30h - 17:00h Via ZOOM: link to meeting Meeting ID: 815 6338 5915, Passcode: 951576
Dr. Cyrielle Caussy
Associate Professor of Nutrition and Endocrinologist
Hospices Civils de Lyon, Lyon 1 University
"High risk population for NAFLD: should we screen for advanced fibrosis?"
Dr Caussy’s main field of research interests are insulin resistance and nonalcoholic fatty liver disease (NAFLD). She has a specific interest in non-invasive biomarkers and pathophysiology of NAFLD especially in high-risk populations such as type 2 diabetes and obese patients.
Dr. Maarten Tushuizen
Hepatologist
Leiden University Medical Center
"Care paths in NAFLD: why, who, where, when and how"
Dr. Maarten Tushuizen's research focusses on NAFLD/NASH, principally development of clinical care paths including diagnostics, surveillance and treatment. Furthermore, his interests are the various aspects (including prevention) of NAFLD/NASH before and after liver transplantation, including posttransplantation diabetes mellitus, hepatocellular carcinoma and cardiovascular disease risk.
EPISODE 4 Owning obesity & negating NASH
THURSDAY
November 26, 2020
15:30h - 17:00h Via ZOOM: link to meeting MeetingID: 886 8548 5340, Passcode: 052368
Prof. Saskia van Mil
Professor of Molecular and Translational Metabolism
University of Utrecht
"Should we selectively target the FXRα2 isoform to improve NASH therapy?"
The research group of Prof. Saskia van Mil investigates the role of bile acid metabolism and the farnesoid X receptor (FXR) in liver energy metabolism. Using the new knowledge obtained, they aim to increase selectivity and efficacy of targeting FXR for NASH.
Dr. Victor Gerdes
Internist at the Department of Vascular Medicine
Amsterdam University Medical Centers
"The treatment of obesity: current options and future perspectives"
Dr. Gerdes is internist at the Department of Vascular Medicine. Being closely involved in the bariatric surgery program at Spaane Gasthuis in Hoofddorp, he has a longstanding interest in obesity and a research line on the metabolic consequences of obesity and the metabolic changes that bariatric surgery induces in liver and gut microbiome.
Online via ZOOM
You are receiving this email because you are on the AGEM mailing list.
Please let us know if you want to be removed from or if someone needs to be added to this list.
